Skip to Content

Join the 'Fludrocortisone' group to help and get support from people like you.

Fludrocortisone News

Imbruvica Approval Expanded to Include Graft Versus Host Disease

Posted 3 Aug 2017 by Drugs.com

WEDNESDAY, Aug. 2, 2017 – The U.S. Food and Drug Administration on Wednesday expanded approval for the anti-cancer drug Imbruvica (ibrutinib) to include adults with chronic graft versus host disease (cGVHD). cGVHD is a deadly condition that affects up to 70 percent of people who receive a stem cell transplant to treat cancers of the blood or bone marrow, the FDA said in a news release. The...

Ask a Question

Further Information

Related Condition Support Groups

Postural Orthostatic Tachycardia Syndrome, Addison's Disease, Dysautonomia

Fludrocortisone Patient Information at Drugs.com